The Medicines Company and Alnylam Pharmaceuticals Report Positive Final Results from ORION-1 Phase II Study of Inclisiran
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 225.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.10 | 52 Week High | $109.10 | |||
| Open | $225.10 | 52 Week Low | $31.38 | |||
| Day High | $225.10 | P/E | N/A | |||
| Day Low | $225.10 | EPS | $-1.45 | |||
| Volume | 625 | |||||
| Medicines Co (NASDAQ: MDCO) | Delayed: 84.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.90 | 52 Week High | $43.00 | |||
| Open | $3.15 | 52 Week Low | $27.50 | |||
| Day High | $84.90 | P/E | 339.60 | |||
| Day Low | $84.90 | EPS | $0.25 | |||
| Volume | 413,822 | |||||
